The US Food and Drug Administration (FDA) said on Monday it has postponed announcing its health and safety assessment of the chemical bisphenol A (BPA). The FDA originally planned to give its decision on the safety of BPA on 30 November. Agency spokesman Michael Herndon did not give a reason for the delay, only saying that an announcement would be “forthcoming”. 美国食品与药物管理局(FDA)星期一表示将推迟原本计划于11月30日宣布的关于双酚A健康和安全的评定结果。其发言人Michael Herndon并没给出任何理由。